
MPHASIS - Mphasis Limited Share Price
IT - Software
Valuation | |
---|---|
Market Cap | 51.29 kCr |
Price/Earnings (Trailing) | 29.4 |
Price/Sales (Trailing) | 3.46 |
EV/EBITDA | 17.18 |
Price/Free Cashflow | 27.82 |
MarketCap/EBT | 21.99 |
Enterprise Value | 51.42 kCr |
Fundamentals | |
---|---|
Revenue (TTM) | 14.8 kCr |
Rev. Growth (Yr) | 9.1% |
Earnings (TTM) | 1.74 kCr |
Earnings Growth (Yr) | 9.2% |
Profitability | |
---|---|
Operating Margin | 16% |
EBT Margin | 16% |
Return on Equity | 18.06% |
Return on Assets | 11.67% |
Free Cashflow Yield | 3.59% |
Price to Sales Ratio
Revenue (Last 12 mths)
Net Income (Last 12 mths)
Growth & Returns | |
---|---|
Price Change 1W | -2.2% |
Price Change 1M | -5.9% |
Price Change 6M | -6% |
Price Change 1Y | 1.9% |
3Y Cumulative Return | 4.1% |
5Y Cumulative Return | 18.3% |
7Y Cumulative Return | 12.9% |
10Y Cumulative Return | 20.3% |
Cash Flow & Liquidity | |
---|---|
Cash Flow from Investing (TTM) | 44.06 Cr |
Cash Flow from Operations (TTM) | 1.91 kCr |
Cash Flow from Financing (TTM) | -1.76 kCr |
Cash & Equivalents | 986.35 Cr |
Free Cash Flow (TTM) | 1.84 kCr |
Free Cash Flow/Share (TTM) | 96.89 |
Balance Sheet | |
---|---|
Total Assets | 14.91 kCr |
Total Liabilities | 5.28 kCr |
Shareholder Equity | 9.63 kCr |
Current Assets | 6.99 kCr |
Current Liabilities | 4.45 kCr |
Net PPE | 821.58 Cr |
Inventory | 0.00 |
Goodwill | 4.29 kCr |
Capital Structure & Leverage | |
---|---|
Debt Ratio | 0.07 |
Debt/Equity | 0.12 |
Interest Coverage | 13.81 |
Interest/Cashflow Ops | 13.09 |
Dividend & Shareholder Returns | |
---|---|
Dividend/Share (TTM) | 57 |
Dividend Yield | 2.11% |
Shares Dilution (1Y) | 0.60% |
Shares Dilution (3Y) | 1.2% |
Risk & Volatility | |
---|---|
Max Drawdown | -12.7% |
Drawdown Prob. (30d, 5Y) | 29.23% |
Risk Level (5Y) | 37.1% |
Latest News and Updates from Mphasis
Updated May 5, 2025
The Bad News
Despite a rise in shares after Q4 earnings, Mphasis stock has fallen 27% in the last six months and is down 10% this year.
Currently trading at Rs 2,460.25, Mphasis stock is down 2.03% from its last closing price, with a yearly decline of 13.28%.
Mphasis has experienced a decline of 14.3% over the past three months, with a -18.3% decrease over six months.
The Good News
Emkay Global Financial Services has reaffirmed its 'Buy' rating on Mphasis Ltd. with a target price of Rs 2,500, citing strong financial performance and investments in digital and AI initiatives as key growth drivers.
Mphasis reported a net profit increase of 13.55% to Rs 446.49 crore for the March 2025 quarter, with sales climbing 8.73% to Rs 3,710.04 crore.
In Q4FY25, Mphasis achieved gross revenues of Rs 3,717.5 crore, reflecting a 2.9% q-o-q growth and a 5.4% y-o-y growth.
Updates from Mphasis
Analyst / Investor Meet • 08 Aug 2025 Intimation of Investor/ Analyst Meet |
Press Release / Media Release • 01 Aug 2025 Flagstar names Mphasis as its Technology modernization partner |
Allotment of ESOP / ESPS • 01 Aug 2025 Exercise of 2000 Stock Options and 448 Restricted Stock Units. |
Earnings Call Transcript • 29 Jul 2025 Earnings Call Transcript |
Newspaper Publication • 26 Jul 2025 Newspaper Publication |
Investor Presentation • 25 Jul 2025 Investor Presentation |
Analyst / Investor Meet • 25 Jul 2025 Audio recording of the Analyst meet. |
This information is AI-generated and may contain inaccuracies. Please verify from multiple sources.
Summary of Latest Earnings Report from Mphasis
Summary of Mphasis's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Last updated:
Management provided a positive outlook for Mphasis Limited, emphasizing their commitment to client-centricity and technology-led transformation. They predict that for FY26, the company expects to achieve growth at approximately twice the industry rate, supported by robust deal wins and effective conversion from TCV to revenue. The target EBIT operating margin is projected to remain within a band of 14.75% to 15.75%.
Key forward-looking points from management include:
Record Deal Wins: Mphasis reported a record Total Contract Value (TCV) win of $760 million in Q1 FY26, with 68% of these wins being AI-led. This includes four large deals, three of which exceeded $100 million.
Pipeline Growth: The deal pipeline has grown by 16% quarter-over-quarter and 84% year-over-year, signaling strong future revenue potential.
Vertical Performance: The BFS, Insurance, and Technology, Media, and Telecommunications (TMT) verticals exhibited robust growth, with all three delivering over 20% year-over-year growth in constant currency.
Investment in AI: Mphasis continues to amplify its AI-led offerings, with a focus on technology innovations that address specific client needs and enhance operational efficiency.
Client Acquisition: The company is expanding its client base, having added one new client in the $100 million+ category and several others across multiple bands.
Overall, Mphasis is positioned to leverage its technological advancements and client trust to navigate current uncertainties and drive significant growth throughout FY26.
Last updated:
Q: With the current good order intake, do you think Mphasis can converge with the growth rates of similar-sized peers?
A: The direction is indeed positive, and we've recovered from previous headwinds. While uncertainties remain, we're pleased with our current trajectory. I can't predict the next three quarters definitively, but if our execution continues effectively, we might find ourselves in a better place. It's crucial for us to maintain rigor in our approach to drive confident outcomes.
Q: Are there any weak spots in BFS, Insurance, or TMT due to macro uncertainties?
A: No, currently, we do not see any weak spots in our portfolio. We've focused on overcoming challenges by creating opportunities through tailored solutions. As of now, nothing appears to be imminent that could lead to slippage in performance.
Q: Is there any sign of fatigue in deal bookings, especially in BFS, Insurance, and Tech?
A: We don't see fatigue in our deal-making. The pipeline remains active, and we've confirmed our growth due to qualified deal origination across sectors including Logistics and Healthcare. We're committed to diligently working through our pipeline, which saw a 16% increase sequentially.
Q: Can you explain the sharp increase in other assets during the quarter?
A: The increase is primarily due to fixed-price projects under IFRS 15, where deliverables not yet accepted are recorded as contract costs. Additionally, large deals required initial savings that count as contract acquisition costs, contributing to this rise. Much of it should convert to unbilled revenue in Q2.
Q: What drove the growth in BFS and Insurance, and what are the structural changes resulting in solid deal wins?
A: Our growth stemmed from effective deal closures stemming from previous momentum. We've been able to bundle technical expertise, which has enhanced our proposition to clients. Over the past few years, investing in specialized technology solutions and an account-based focus helped us drive significant change and deal wins.
Q: Given margin stability despite declines in Logistics, what contributed to this?
A: While we saw gross margin declines in Logistics due to investments, other verticals improved, which helped stabilize our overall margins. There were no one-off impacts; the growth allowed us to offset costs. Our focus has been on improving efficiency through better utilization across business units.
Q: Looking forward, what can we expect in terms of revenue conversion from the recent deal wins?
A: The ramp-up depends on the nature of each deal. We expect a balanced set of deals won during the quarter, with the potential for revenue to convert within 1-2 quarters. However, some deals require time for full transition, so our outlook remains cautious but optimistic.
Q: Is the growth goal of roughly double the industry realistic given current momentum?
A: Yes, but we're taking a measured approach due to macro uncertainties and ongoing transitions. It's essential to maintain careful execution and not stretch too far too quickly. We'll watch how the visibility improves over the next quarters before making any bold predictions.
Q: Can you clarify the nature of recent investments, including in Locate Software?
A: Our investment in Locate Software stems from a customer consolidation initiative rather than a traditional acquisition. This reflects a venture where we integrate new contracts while hiring employees previously associated with the service. This falls under interconnected operational adjustments that keep us aligned with ongoing market needs.
Revenue Breakdown
Analysis of Mphasis's financial performance, highlighting revenue trends, growth patterns, and key metrics through quarterly analysis.
Last Updated: Jun 30, 2025
Description | Share | Value |
---|---|---|
Banking and Financial Services | 52.7% | 2 kCr |
Technology Media and Telecom | 18.1% | 675.7 Cr |
Insurance | 13.7% | 510.5 Cr |
Others | 9.7% | 362.9 Cr |
Logistics and Transportation | 5.8% | 217.1 Cr |
Total | 3.7 kCr |
Share Holdings
Understand Mphasis ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
Holding Pattern
Share Holding Details
Shareholder Name | Holding % |
---|---|
BCP TOPCO IX PTE. LTD | 40.1% |
KOTAK EMERGING EQUITY SCHEME (including other Kotak mutual funds consolidated based on PAN) | 7.58% |
LIFE INSURANCE CORPORATION OF INDIA (including other LIC funds consolidated based on PAN) | 6.53% |
HDFC MUTUAL FUND - HDFC MID-CAP OPPORTUNITIES FUND(including other HDFC mutual funds consolidated based on PAN) | 3.24% |
MIRAE ASSET EMERGING BLUECHIP FUND (including other Mirae mutual funds consolidated based on PAN) | 2.51% |
ICICI PRUDENTIAL MUTUAL FUND (including other ICICI Prudential mutual funds consolidated based on PAN) | 2.42% |
HDFC LIFE INSURANCE COMPANY LIMITED (including other HDFC funds consolidated based on PAN) | 1.3% |
SBI LIFE INSURANCE CO. LTD | 1.2% |
FRANKLIN INDIA PRIMA FUND(including other Franklin India Prima Fund consolidated based on PAN) | 1.19% |
UTI Value fund (including other UTI mutual funds consolidated based on PAN) | 1.13% |
DSP LARGE AND MIDCAP FUND (including other DSP LARGE AND MIDCAP FUND consolidated based on PAN) | 1.02% |
Insurance Funds-Department Of Post India | 0.23% |
BCP Asia (SG) Mirror Holding Pte. Ltd. | 0% |
Overall Distribution
Distribution across major stakeholders
Ownership Distribution
Distribution across major institutional holders
Is Mphasis Better than it's peers?
Detailed comparison of Mphasis against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|---|
TCS | Tata Consultancy Services | 10.97 LCr | 2.61 LCr | -10.40% | -27.40% | 22.26 | 4.21 | - | - |
INFY | Infosys | 5.91 LCr | 1.7 LCr | -12.90% | -18.40% | 21.62 | 3.48 | - | - |
HCLTECH | HCL Tech | 4 LCr | 1.21 LCr | -11.80% | -5.30% | 23.56 | 3.3 | - | - |
WIPRO | Wipro | 2.51 LCr | 93.48 kCr | -10.60% | -1.80% | 18.6 | 2.68 | - | - |
TECHM | Tech Mahindra | 1.45 LCr | 54.26 kCr | -8.20% | +1.10% | 28.92 | 2.68 | - | - |
Sector Comparison: MPHASIS vs IT - Software
Comprehensive comparison against sector averages
Comparative Metrics
MPHASIS metrics compared to IT
Category | MPHASIS | IT |
---|---|---|
PE | 29.40 | 23.24 |
PS | 3.46 | 3.60 |
Growth | 8.1 % | 5.6 % |
Performance Comparison
MPHASIS vs IT (2021 - 2025)
- 1. MPHASIS is among the Top 10 Computers - Software & Consulting companies but not in Top 5.
- 2. The company holds a market share of 1.8% in Computers - Software & Consulting.
- 3. In last one year, the company has had an above average growth that other Computers - Software & Consulting companies.
Income Statement for Mphasis
Balance Sheet for Mphasis
Cash Flow for Mphasis
What does Mphasis Limited do?
Mphasis is a Computers - Software & Consulting company with the stock ticker MPHASIS.
It has a market cap of Rs. 47,479 Crores and is primarily engaged in providing information technology solutions. Mphasis specializes in cloud and cognitive services, operating across several regions including the United States, India, Europe, the Middle East, and Africa.
The company is structured into multiple segments such as:
- Banking and Financial Services
- Logistics and Transportation
- Technology Media and Telecom
- Insurance
- Others
Mphasis offers a wide range of services including application development, blockchain technology, business process management, cognitive services, cyber security, DevOps, artificial intelligence, digital solutions, enterprise automation, design, infrastructure modernization, and data and product engineering. The company also focuses on governance, risk, and compliance services and provides platform and protocol services under Mphasis XaaP.
Mphasis serves various industries including:
- Asset management
- Corporate banking
- Investment banking
- Mortgage and retail banking
- Wealth management and brokerage
- Insurance and payments
- Healthcare and life sciences
- Logistics and manufacturing
Founded in 1992 and headquartered in Bengaluru, India, Mphasis has demonstrated financial strength with a trailing revenue of Rs. 14,191.2 Crores over the past 12 months.
The company is also shareholder-friendly, distributing dividends with a yield of 1.98% per year, having returned Rs. 55 in dividends per share in the last year. Although it has diluted shareholder holdings by 1.2% in the past three years, Mphasis remains profitable, reporting a profit of Rs. 1,648.9 Crores in the last four quarters. Additionally, it has achieved a revenue growth rate of 24.9% over the past three years.